Evolution of Evidence-Based Outcomes for Percutaneous Management

Matthew J. O'Shaughnessy, David A. Leavitt, J. Kyle Anderson

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Percutaneous ablation has been developed over the last two decades to provide a minimally invasive treatment option for patients with renal masses. Despite increased use of this technology, data on percutaneous ablation are largely limited to observational studies with little significant comparison with other treatment options. Within these limitations, percutaneous ablation is proving to be a very viable alternative for selected patients, especially those with small renal masses and/or comorbidities that may limit more invasive treatments.

Original languageEnglish (US)
Title of host publicationPercutaneous Renal Surgery
PublisherWiley
Pages215-223
Number of pages9
ISBN (Electronic)9781118670903
ISBN (Print)9781118278734
DOIs
StatePublished - Oct 28 2013

Keywords

  • Cryoablation
  • Kidney cancer
  • Radiofrequency ablation
  • Renal cell carcinoma

Fingerprint Dive into the research topics of 'Evolution of Evidence-Based Outcomes for Percutaneous Management'. Together they form a unique fingerprint.

Cite this